The identified CCL proteins have various carcinogenetic properties, such as the increase in breast cancer cell proliferation, chemoresistance development and T-cell and NK-cell regulation (CCL8), stimulation of angiogenesis and cancer cell proliferation (CCL23) and control of cell migration (CCL28) [30–33]. Here, CCL28 is linked to breast cancer.